JB

Mumbai, India Founded: 1976 • Age: 50 yrs Acquired By Torrent Pharma
Generic drugs are manufactured by JB in Mumbai, India.
Annual revenue $455.6M Latest available
Total funding - Funding intelligence
Employees 7650 Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About JB

JB is a company based in Mumbai (India) founded in 1976 was acquired by Torrent Pharma in June 2025. The company has 7,650 employees as of March 31, 2024. JB offers products and services including Pharmaceutical Formulations and Lozenges.

  • Headquarter Mumbai, India
  • Employees 7650 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Jb Chemicals & Pharmaceuticals Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $455.56 M (USD)
    12.25
    as on Mar 31, 2025
  • Net Profit
    $77.25 M (USD)
    19.35
    as on Mar 31, 2025
  • EBITDA
    $119.04 M (USD)
    13.88
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    KKR

    & 1 more

  • Employee Count
    7650

    as on Mar 31, 2024

  • Acquired by
    Torrent Pharma

    & 1 more

    (Jun 29, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of JB

JB is a publicly listed company on the NSE with ticker symbol JBCHEPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: JBCHEPHARM · Sector: Health technology · India

Products & Services of JB

JB offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Lozenges.

Product name locked
Category locked
Primary

Formulations are manufactured across various therapeutic categories to meet global demands.

Product name locked
Category locked
Locked

Lozenges are developed and supplied for therapeutic purposes in multiple markets.

People of JB

Headcount 1000-5000
Employee Profiles 46
Board Members and Advisors 2
Employee Profiles
People
Kunal Khanna
President – Operations
People
Neel Jani
Senior Quality Assurance Officer
People
Amit Nayak
Assistant Vice President, Commercial Excellence Head
People
Deepak Goswami
TM J.b. Chemical And Pharmaceutical Ltd

Unlock access to complete

Board Members and Advisors
people
Prachi Karekar
Senior Executive - CRM

Unlock access to complete

Funding Insights of JB

Premium access

Detailed funding history for JB

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in JB

JB has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR and Torrent Pharma.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Multiple sectors are invested in by this private equity firm.
Locked Locked Locked
Formulations, APIs, drug discovery, marketing, and sales services are provided.
Locked Locked Locked
Premium access

Investor details for JB

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by JB

Investments
Premium access

Investment portfolio details for JB

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - JB

Premium access

Detailed financials for JB

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jb Comparisons

JB Primary company
Description
Generic drugs are manufactured by JB in Mumbai, India.
Location
Mumbai, India
Founded Year
1976
Annual Revenue
$455.56 M (USD)
Net Profit
$77.25 M (USD)
EBITDA
$119.04 M (USD)
Employees
7,650
As of 2024
Premium access

Peer comparison for JB

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of JB

Premium access

Detailed competitors of JB

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jb

Premium access

Complete news archive for JB

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JB

JB was founded in 1976.

JB is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Nikhil Chopra is the current CEO of JB.

As of Mar 31, 2024, the latest employee count at JB is 7,650.

Annual revenue of JB is $455.56M as on Mar 31, 2025.

JB was established in 1976 in Mumbai, India, within the pharmaceutical sector. Generic drugs are produced by the company, focusing on manufacturing operations. The headquarters are located in Mumbai, where core activities are managed. Nikhil Chopra is designated as CEO. The companys online presence is maintained through the domain jbpharma.com. Geographic focus remains centered in India for production and distribution.

JB offers Pharmaceutical Formulations and Lozenges.

Yes, JB is publicly traded on NSE under the ticker symbol JBCHEPHARM.

JB has 2 investors. Key investors include KKR, and Torrent Pharma.

The ticker symbol of JB is JBCHEPHARM on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available